Psychosocial Correlates of Gap Time to Anabolic-androgenic Steroid Use

Overview

Journal Int J Eat Disord

Publisher Wiley

Specialty Social Sciences

Date 2018 Mar 16

PMID 29542171

Citations 3

Authors

Patrycja Klimek

Tom Hildebrandt

Affiliations

Soon will be listed here.

Abstract

Objective: Theoretically, legal supplement use precedes and increases the risk for illicit appearance and performance enhancing drug (APED) use-also referred to as the gateway hypothesis. Little is known about associations between the speed of progression, or gap time, from legal to illicit APED use, and psychological risk factors, such as sociocultural influence, eating disorders, body image disturbance, and impulsivity.

Method: The sample taken from two studies included 172 active steroid users (n = 143) and intense-exercising healthy controls (n = 29) between the ages of 18 and 60 (M = 34.16, SD = 10.43), the majority of whom were male (91.9%). Participants, retrospectively, reported APED use and completed measures assessing psychological and behavioral factors, including eating concern, muscle dysmorphia, and impulsivity. Participants had a gap time from initial APED use to anabolic-androgenic steroid (AAS) use that ranged from 0 to 38 years.

Results: Continuous survival analysis indicated that interactions between self- versus other sociocultural influence on APED onset and both higher eating concern and impulsivity are associated with a shorter gap time from initial legal to illicit APED use.

Discussion: The results indicate the potential value in developing different strategies for individuals with other sociocultural versus self-influence on illicit APED use, and among more impulsive and eating-concerned APED users. Future research is needed to assess different trajectories of APED use, such that eating-concerned and impulsive individuals who perceive less other sociocultural influence may be at greatest risk for a speedier progression to AAS use.

Citing Articles

The Susceptibles, Chancers, Pragmatists, and Fair Players: An Examination of the Sport Drug Control Model for Adolescent Athletes, Cluster Effects, and Norm Values Among Adolescent Athletes.

Nicholls A, Levy A, Meir R, Sanctuary C, Jones L, Baghurst T Front Psychol. 2020; 11:1564.

PMID: 32754092 PMC: 7366030. DOI: 10.3389/fpsyg.2020.01564.

An instrument for the evaluation of muscle dysmorphia: The Italian validation of the adonis complex questionnaire.

Riccobono G, Pompili A, Iorio C, Carducci G, Parnanzone S, Pizziconi G Brain Behav. 2020; 10(7):e01666.

PMID: 32469110 PMC: 7375086. DOI: 10.1002/brb3.1666.

The association between muscle dysmorphia and eating disorder symptomatology: A systematic review and meta-analysis.

Badenes-Ribera L, Rubio-Aparicio M, Sanchez-Meca J, Fabris M, Longobardi C J Behav Addict. 2019; 8(3):351-371.

PMID: 31505966 PMC: 7044626. DOI: 10.1556/2006.8.2019.44.

References

Kaufman M, Janes A, Hudson J, Brennan B, Kanayama G, Kerrigan A . Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015; 152:47-56. PMC: 4458166. DOI: 10.1016/j.drugalcdep.2015.04.023. View

Kanayama G, Hudson J, Pope Jr H . Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?. Drug Alcohol Depend. 2008; 98(1-2):1-12. PMC: 2646607. DOI: 10.1016/j.drugalcdep.2008.05.004. View

Hildebrandt T, Harty S, Langenbucher J . Fitness supplements as a gateway substance for anabolic-androgenic steroid use. Psychol Addict Behav. 2012; 26(4):955-62. PMC: 3838896. DOI: 10.1037/a0027877. View

Griffiths S, Murray S, Touyz S . Disordered eating and the muscular ideal. J Eat Disord. 2014; 1:15. PMC: 4081800. DOI: 10.1186/2050-2974-1-15. View

McCabe M, Ricciardelli L . Parent, peer, and media influences on body image and strategies to both increase and decrease body size among adolescent boys and girls. Adolescence. 2001; 36(142):225-40. View

Pope Jr H, Kouri E, Hudson J . Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000; 57(2):133-40; discussion 155-6. DOI: 10.1001/archpsyc.57.2.133. View

Murray S, Rieger E, Hildebrandt T, Karlov L, Russell J, Boon E . A comparison of eating, exercise, shape, and weight related symptomatology in males with muscle dysmorphia and anorexia nervosa. Body Image. 2012; 9(2):193-200. DOI: 10.1016/j.bodyim.2012.01.008. View

Evans Jr M, Ndetan H, Perko M, Williams R, Walker C . Dietary supplement use by children and adolescents in the United States to enhance sport performance: results of the National Health Interview Survey. J Prim Prev. 2012; 33(1):3-12. DOI: 10.1007/s10935-012-0261-4. View

Vanyukov M, Tarter R, Kirillova G, Kirisci L, Reynolds M, Kreek M . Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. Drug Alcohol Depend. 2012; 123 Suppl 1:S3-17. PMC: 3600369. DOI: 10.1016/j.drugalcdep.2011.12.018. View

10.

Evans N . Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004; 32(2):534-42. DOI: 10.1177/0363546503262202. View

11.

Hildebrandt T, Langenbucher J, Carr S, Sanjuan P . Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users. J Abnorm Psychol. 2007; 116(4):717-33. DOI: 10.1037/0021-843X.116.4.717. View

12.

Fairburn C, Beglin S . Assessment of eating disorders: interview or self-report questionnaire?. Int J Eat Disord. 1994; 16(4):363-70. View

13.

Field A, Austin S, Camargo Jr C, Taylor C, Striegel-Moore R, Loud K . Exposure to the mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents. Pediatrics. 2005; 116(2):e214-20. DOI: 10.1542/peds.2004-2022. View

14.

Foster A, Shorter G, Griffiths M . Muscle dysmorphia: could it be classified as an addiction to body image?. J Behav Addict. 2015; 4(1):1-5. PMC: 4394845. DOI: 10.1556/JBA.3.2014.001. View

15.

Dodge T, Jaccard J . The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J Adolesc Health. 2006; 39(3):367-73. DOI: 10.1016/j.jadohealth.2005.12.025. View

16.

Sagoe D, Andreassen C, Pallesen S . The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abuse Treat Prev Policy. 2014; 9:27. PMC: 4091955. DOI: 10.1186/1747-597X-9-27. View

17.

Hildebrandt T, Alfano L, Langenbucher J . Body image disturbance in 1000 male appearance and performance enhancing drug users. J Psychiatr Res. 2010; 44(13):841-6. PMC: 2889003. DOI: 10.1016/j.jpsychires.2010.01.001. View

18.

Hildebrandt T, Lai J, Langenbucher J, Schneider M, Yehuda R, Pfaff D . The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug Alcohol Depend. 2010; 114(1):1-11. PMC: 3039045. DOI: 10.1016/j.drugalcdep.2010.09.018. View

19.

Bailey R, Fulgoni 3rd V, Keast D, Dwyer J . Examination of vitamin intakes among US adults by dietary supplement use. J Acad Nutr Diet. 2012; 112(5):657-663.e4. PMC: 3593649. DOI: 10.1016/j.jand.2012.01.026. View

20.

MacKinnon D, Goldberg L, Clarke G, Elliot D, Cheong J, Lapin A . Mediating mechanisms in a program to reduce intentions to use anabolic steroids and improve exercise self-efficacy and dietary behavior. Prev Sci. 2001; 2(1):15-28. DOI: 10.1023/a:1010082828000. View